Literature DB >> 6281375

Suppression of fibronectin synthesis by an early function(s) of human cytomegalovirus.

S Ihara, S Saito, Y Watanabe.   

Abstract

Labelling of fibronectin with [3H]leucine and its isolation by immunoprecipitation followed by electrophoresis on gels showed that fibronectin synthesis was specifically suppressed in human embryonic cells infected with human cytomegalovirus. Degradation or release of pre-existing fibronectin into the medium was not affected. The inhibition of fibronectin synthesis was also observed when cells were infected with a DNA-minus temperature-sensitive mutant at the non-permissive temperature but not observed in infection with u.v. -irradiated virus, suggesting the involvement of the expression of an early virus function(s). This capacity of the virus may be implicated in the virus-induced early cell rounding.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281375     DOI: 10.1099/0022-1317-59-2-409

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Viral replication in HeLa/fibroblast hybrid cells infected with human cytomegalovirus.

Authors:  Y Tsutsui; S Sonta; A Kashiwai; T Nogami; T Furukawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Altered expression of fibronectin gene in cells infected with human cytomegalovirus.

Authors:  H Pande; T Terramani; T Tressel; M A Churchill; G G Hawkins; J A Zaia
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Distinction of viral and host-derived glycopolypeptides induced by "early" functions of human cytomegalovirus.

Authors:  K Radsak; I Mertensmaier; C Kaiser; C Wagner
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

4.  Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression.

Authors:  R J Stanton; B P McSharry; C R Rickards; E C Y Wang; P Tomasec; G W G Wilkinson
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.